Business
Baird Medical Accelerates U.S. Expansion at NASOIE 2026
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation at the 2026 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Miami, Florida. Building on successful engagements at previous NASOIE gatherings, this initiative reinforces the Company's enduring commitment to physician education and advances its strategy to expand pa
About this update from Baird Medical Investment Holdings Ltd
[{"type":"text","content":"NEW YORK, March 2, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation at the 2026 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Miami, Florida. Building on successful engagements at previous NASOIE gatherings, this initiative reinforces the Company's enduring commitment to physician education and advances its strategy to expand patient access to minimally invasive therapies.","length":609,"tagName":"p"},{"type":"image","alt":"Baird continues its engagement with top-tier clinicians, pictured here at NASOIE 2025","displaySize":"","headline":null,"caption":"Baird continues its engagement with top-tier clinicians, pictured here at NASOIE 2025","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":231,"url":"https://media.zenfs.com/en/prnewswire.com/f16cc2071450e5d096f69586ee3b4719"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/S0DLuq7w0zDdRQJvwIRXeA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQwNztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/f16cc2071450e5d096f69586ee3b4719","width":400,"height":231}},"href":"https://mma.prnewswire.com/media/2923096/nasoie_2025.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"NASOIE convenes top-tier clinicians to exchange advanced methodology in interventional endocrinology. At the event, Baird Medical engaged in discussions with attending physicians regarding the clinical applications and efficacy of its proprietary MWA technology. Through these interactions, the Company provided specialists with practical insights into integrating these advanced tools into their practice to achieve superior patient outcomes.","length":443,"tagName":"p"},{"type":"text","content":"The clinical feedback gathered in Miami will directly inform Baird Medical's commercial roadmap. The Company remains focused on delivering innovative medical devices that address a broad spectrum of clinical applications with unmatched precision.","length":250,"tagName":"p"},{"type":"text","content":"About Baird Medical ","length":19,"tagName":"p"},{"type":"text","content":"Baird Medical is a forward-thinking medical device company specializing in min...